This suggests that GLP-1 receptor activation alone may not substantially increase deficiency risk
doi: 10.3389/fendo.2022.818537 63
For example, the combination of metformin and liraglutide is being investigated for both metabolic parameters and fertility outcomes in late-stage clinical trials (Phase III), alongside eight other antidiabetics in Phase III
Enjoy the benefits of twice weekly Lipo-C injections in the comfort of your own home
GLP-1 medications have been FDA-approved and clinically proven safe for weight management when prescribed appropriately
As more medication options become available, it is critical for people living with obesity to work with clinicians who understand the disease and multi-modal treatment and who can offer comprehensive, evidence-based care, not just prescribing, so patients achieve real-world health results on par with clinical trials